Recent Patents of Interest in Proteomics

US Patent No. 8,642,534. Proteins and polynucleotides of Vibrio cholerae. Inventor: Fitnat Yildiz. Assignee: University of California

Covers use of proteins encoded by the rbmBCDEF gene cluster and by bap1 for Vibrio cholerae diagnostic, therapeutic, and environmental monitoring purposes.


US Patent No. 8,642,347. Urinary CA125 peptides as biomarkers of ovarian cancer. Inventors: Bin Ye; Daniel Cramer. Assignee: The Brigham and Women's Hospital

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.